SCHEMBL2072998

SCHEMBL2072998

O=C1OCCc2nc(-c3ccc(C(F)(F)F)cc3)sc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TNKS2 Q9H2K2 7/20 0.42
▸ WNT3A P56704 5/20 0.42
▸ TNKS O95271 6/20 0.39
▸ NPC1 O15118 2/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ MAPT P10636 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ PARP1 P09874 5/20 0.37
▸ PARP2 Q9UGN5 4/20 0.37
▸ KDM4E B2RXH2 2/20 0.37
▸ PARP14 Q460N5 1/20 0.37
▸ PARP4 Q9UKK3 1/20 0.37
▸ AXIN2 Q9Y2T1 1/20 0.37
▸ PARP3 Q9Y6F1 1/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ HSP90AA1 P07900 1/20 0.37
▸ CRHBP P24387 1/20 0.37
▸ KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2074075 0.82 ALDH1A1 (0.42) TNKS2WNT3ANPC1ALDH1A1GAA
SCHEMBL2075217 0.79 ALOX5 (0.48) TNKS2WNT3ANPC1ALDH1A1GAA
SCHEMBL2073156 0.74 KMT2A (0.43) NPC1ALDH1A1MAPTSMN1; SMN2RAB9A
SCHEMBL2073946 0.68 RAB9A (0.40) NPC1ALDH1A1GAAMAPTSMN1; SMN2
SCHEMBL25028118 0.66 KIF11 (0.48) NPC1ALDH1A1GAAMAPTSMN1; SMN2
SCHEMBL1261819 0.65 PDCD1 (0.49) TNKS2WNT3ATNKSNPC1ALDH1A1
SCHEMBL3837962 0.65 TLR9 (0.47) —
SCHEMBL8310977 0.64 TNKS (0.43) TNKS2WNT3ATNKSNPC1ALDH1A1
SCHEMBL6370493 0.64 KIF11 (0.49) NPC1ALDH1A1GAAMAPTSMN1; SMN2
Hydrochloric Acid SCHEMBL1262005 0.64 PDCD1 (0.48) TNKS2WNT3ATNKSNPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7902356-B2 Thiazolopyridinone derivates as MCH receptor antagonists ELI LILLY AND COMPANY (US) 2011-03-08 — — US disclosed
US-7902356-B2 Thiazolopyridinone derivates as MCH receptor antagonists ELI LILLY AND COMPANY (US) 2011-03-08 — — US disclosed
US-7902356-B2 Thiazolopyridinone derivates as MCH receptor antagonists ELI LILLY AND COMPANY (US) 2011-03-08 — — US disclosed
EP-1828207-B1 THIAZOLOPYRIDINONE DERIVATES AS MCH RECEPTOR ANTAGONISTS LILLY CO ELI (US) 2009-10-28 — — EP disclosed
EP-1828207-B1 THIAZOLOPYRIDINONE DERIVATES AS MCH RECEPTOR ANTAGONISTS LILLY CO ELI (US) 2009-10-28 — — EP disclosed
US-20090233919-A1 THIAZOLOPYRIDINONE DERIVATES AS MCH RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY 2009-09-17 — — US disclosed
US-20090233919-A1 THIAZOLOPYRIDINONE DERIVATES AS MCH RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY 2009-09-17 — — US disclosed
US-20090233919-A1 THIAZOLOPYRIDINONE DERIVATES AS MCH RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY 2009-09-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090233919-A1 THIAZOLOPYRIDINONE DERIVATES AS MCH RECEPTOR ANTAGONISTS MCHR1, MCHR2, MC1R TNKS2 4124/4885WNT3A 797/4885TNKS 3646/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback